å»çæ©åšå ¬è¡šãããæŽå¯
åžå ŽæŠèгç±ç»åæè¡ã¯ããªããžã§ã¯ãã«ãã£ãŠæŸåºãããèµ€å€ç·æŸå°ã®æ€åºãšããããã®æŸå°ç·ãè§£éããŠãå¯èŠãã¿ãŒã³(ç»å)ãäœæããããšã§ããªããžã§ã¯ãã®å¯èŠæ§ãé«ããæ¹æ³ã§ãã ãã®æè¡ã¯èµ€å€ç·å ã¹ãã¯ãã«ã®äžéšã®å±€ãæç²ããŸãã åšå²å ã®ãªãæãç°å¢ã§æé«ã®äœåã§ãé§ãç ããã€ãºããããŠãªã¢ã«ã¿ã€ã ã§åãç©äœããã£ããããããšãã§ããŸãã ãµãŒãã«ã€ã¡ãŒãžã³ã°ããã€ã¹ã«ã¯ãéå·åŽããã€ã¹ãšäœæž©å·åŽããã€ã¹ã2çš®é¡ãããŸãããµãŒãã«ã€ã¡ãŒãžã³ã°åžå Žã¯ã US$ 1,978.7 ã¡ãŒãã« 2019幎ã¯äŸ¡å€ã®èгç¹ããæé·ãèŠèŸŒãŸãã 9.7%ã®CAGR æéã«ã€ã㊠2020幎2æ27æ¥ãåãåãã... ãã£ãšèŠã
å»ççšäœ¿ãæšãŠã¯ãç é¢ãææçã®äºé²ãå»çåºæºãæºããå®å šå¯Ÿçã®ããã«ãããŸããŸãªå»çåéã§äœ¿çšããã補åã§ãã å»ççšäœ¿ãæšãŠã¯ãäžççãªå»çå°éå®¶ãæ¿åºã®ç¬¬äžæ¬¡ç®çã§ããã¯ãã¹æ±æããã³ææçã®å±éºæ§ãäœäžãããããšãéèŠã§ããã€ã³ãã©ã¡ãŒã·ã§ã³ ã°ããŒãã«ã»ç±³åœå»çäœ¿ãæšãŠåžå Ž å£åº§ã«ç³ã蟌ã US$ 55.3 ã¡ãŒãã« å€ã®é¢ã§ 2020幎1æ19æ¥ ãããŠå°éããäºå® US$ 75.2 ã¡ãŒãã« çµäºãŸã§ã« 2027幎ãåãåããã°ããŒãã« ç±³åœå»åŠã®äœ¿ãæšãŠå¯èœ åžå Ž: ãã©ã€ããŒæ ¢æ§çŸæ£ã®æ®åã¯ãäºæž¬æéã«ããã£ãŠãäžçããã³ç±³åœã®å»ççšãã£ã¹ããŒã¶ãã«åžå Žã®æé·ãä¿é²ããããšã... ãã£ãšèŠã
ã³ã³ãã¥ãŒã¿å/èªååãããå èŠé¡ Reprocessors ã¯ãå èŠé¡ãååŠçãããã«ã¹ã±ã¢èšå®ãšããŠåºãå©çšãããéèŠãªå»çæ©åšã§ããäŸãã°ãduodenoscopes ããã³å èŠé¡ã®ä»å±åã¯ãååŠçäžã«ããããæ» èããŸãã èªåå èŠé¡ååŠçè£ çœ®ã¯ãå€é¢ãšå éšãã£ãã«ãè§£æããããšã«ãããå䜿çšå¯èœãªå èŠé¡ã«åŸ®çç©ã殺ãããšãç®çãšããŠããŸãäžççãªèªååå èŠé¡ãªããã»ããµãŒ åžå Žã¯ã US$424.8 Mn å€ã®é¢ã§ãå°éããæåŸ US$ 706.3 ã¡ãŒãã« çµäºãŸã§ã« 2027幎ãåãåããã°ããŒãã« èªåå èŠé¡æ€æ»è£ 眮 åžå Ž: ãã©ã€ããŒããªã¥ãŒããŒã¹ãã«ã¹ã±ã¢ã¢ãã«ãžã®ã·ããã¯ã... ãã£ãšèŠã
ãããŒãã«ããŒã¯ããã©ã³ã¹ãã©ãŒã ããã©ã³ã¹è ã®è¶ 鳿³¢ãªã©ã®å»çæ€æ»äžã«äº€å·®æ±æãé²ãããã«èšèšãããç©ççãªéå£ã§ãã ãŸããæ£è æ§ãã¹ã¿ããã®æå±€ããä¿è·ããããšã§ãç é¢ã®ææã®ãªã¹ã¯ãäœæžãããããŒãã«ããŒã§ãã ãããŒãã«ããŒã¯ç°ãªã圢ç¶ã§å©çšã§ããŸãã ãããŒãã«ããŒã¯ãå®å šãªèšºææè¡ãæäŸããããã«ã©ããã¯ã¹è£œã§ãã ãããŒãã«ããŒã¯ããããŒããæ€æ»é åãããã²ãŒãããã®ã«åœ¹ç«ã€ãšã³ãã§äžžããããŸããè¶ é³æ³¢ã®éèŠã¯å¿è¡ç®¡çŸæ£ã®èå»¶æ§ãé«ããããã«è¿å¹Žå¢å ããŸããã å°¿è·¯ææçäºæž¬æéã«ããã£ãŠã©ããã¯ã¹ãããŒãã«ã㌠åžå Žã®æé·ãä¿é²ããããšãæåŸ ããããããã³ãããäžççãªã©ãã... ãã£ãšèŠã
å èŠé¡æ€æ»ã¯ãå èŠé¡ã身äœã®éå£(ããŠã¹ããªãŒã¹ãªã©)ãéããŠäœå ã§é 眮ãããããäœã«å°ããªåéãããããšã«ãã£ãŠæå°éã®äŸµè¥²çåŠçœ®ã§ãã å èŠé¡ã¯å èŠé¡æ€æ»ã®æé ã§çšããããå»çæ©åšã§ãå èã®èгå¯ãšæ²»çãè¡ã£ãŠããŸããçµ±èš:ã¢ãžã¢å€ªå¹³æŽ å èŠé¡æ€æ» ããã€ã¹åžå Žã¯ã US$11,032.5 Mn å€ã®é¢ã§ 2020幎1æ19æ¥ ãããŠå°éããäºå® US$18,551.0 Mn çµäºãŸã§ã« 2027幎ãåãåããã¢ãžã¢ãã·ãã£ãã¯å èŠé¡æ€æ»è£ 眮 åžå Ž: ãã©ã€ããŒã¢ãžã¢ãã·ãã£ãã¯å èŠé¡æ€æ»è£ 眮ã®åžå Žãäºæž¬æéã«ããã£ãŠæšé²ããããšãæåŸ ãããæ¶ååšçŸæ£ã®æ®åãæåŸ ãããŠããŸãã ããšãã°ã2... ãã£ãšèŠã
Ophthalmologyã®ã»ã¯ã¿ãŒã¯ããŸããŸãªèšºæè£ 眮ãå€ç§ããã·ãŒãžã£ããã³ä»ã®è£ 眮ã®åºãç¯å²ãæž¡ããŸãã ãããã¯çŒç§ç£æ¥ã®é©åãªæ©èœæ§ãä¿éããããã«éèŠãªåŽé¢ã圢äœããŸãã 蚺æè£ 眮ã¯çŒçããã³äžå¿åºåã®è©³çŽ°ãªæ€æ»ãè¡ãªãããã«çŒç§éå®³ã®æ±ºå®ã§å©ããçŒç§å»ãå©ããŸããäžççãªçŒç§ã®èšºæããã³å€ç§è£ 眮åžå Žã¯ã®ããã®èæ ®ã«æšå®ãããŸã US$ 43,047.7 Mn å€ã®é¢ã§ 2020幎1æ19æ¥ ãããŠå°éããäºå® US$ 67,449.1 Mn çµäºãŸã§ã« 2027幎ãåãåããäžçã®çŒç§ã®èšºæããã³å€ç§è£ 眮åžå Ž:éè»¢è æ¥åé害ã®å¢å€§ã¯ãäºæž¬æéã«ããã£ãŠäžççãªçŒç§èšºæããã³æè¡æ©... ãã£ãšèŠã
å€ç§çž«åç·åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžçã®å€ç§çž«åç·ã®åžå ŽèŠæš¡ã¯è©äŸ¡ããããšæšå®ãããŸã 2026幎ã®USD 5.7åãã«ãUSD 9.8åãã«ã«éããèŠèŸŒã¿ 2033幎ã7.8%ã®ååç©ã®å¹Žéæé·ç(CAGR)ãç»é² 2026幎ãã2033幎ãŸã§ã®äºæž¬æéããããã£ãŒã«å€ç§çž«åç·ã®åžå Žã¯äœ¿çšããããããã¯ãã®åºãç¯å²ãå«ãã§ããŸã ãåãåãã ãã°ã€ã³ ã¯ããŒãžã£ ãããŠãã£ãã·ã¥ã®ä¿®çã äž»èŠè£œåã¯åžåå¯èœãªçž«åã§ã äœå ã§åŸã ã«å£åãã倩ç¶ãŸãã¯åæç©è³ªããã ãã€ãã³ãããªãããã¬ã³ãã¹ãã³ã¬ã¹éŒãªã©ã®éåžåçž«å é€å»ãå¿ èŠãšããéŒéã çž«åãåçš® åäžã¹ãã©ã³ãã... ãã£ãšèŠã
è»éªšã¯ã身äœã®ããŸããŸãªéšåã«ååšããçµåçµç¹ãšããŠæ©èœããã¿ãã§äŒžçž®æ§ã®ããææã§ãã èã®è»éªšã¯èã®æ¥åç®æã®éªšãäžç·ã«æ¡ãè¯ãã䌞瞮æ§ãããã¯ãã·ã§ã³ãã£ããã®ãã£ãã·ã¥ã§ãã èè»éªšã¯ãèé¢ç¯ã®æ©æŠãæããè¡æåžåå€ãšããŠäœçšããèº«äœæŽ»åäžã«ãµããŒãããã®ã«åœ¹ç«ã€ãããäœã«äžå¯æ¬ ã§ãã ããããã¹ããŒã掻åãé¢ç¯ã®å調䜿çšãå 倩ç°åžžããã³ãã«ã¢ã³é害ãå ±åéçºã«åœ±é¿ãåãŒããšè¢«å®³ãåŒãèµ·ããããŸããæå·ããèè»éªšã®ä¿®çã®ããã®ããŸããŸãªæé ã¯ãè»éªšã修埩ãã£ãã·ã¥ã§å å¡«ããããšãå«ã¿ãŸãã ãã倧ããªæ¬ é¥ã¯ããªãŒãããžã¹ã»ã³ã³ãã¬ãŒãµãŒã»ãã©ã³ã¹ãã©ã³ããŸãã¯éªšè»éªšã³ã³ãã©ã«ã»ã¢ãœã°ã©... ãã£ãšèŠã
å€ç§ããŒããšãåŒã°ããå»åŠã®éæ°æ§ããŒãã¯ãäžè¬çã«åµå·ã«å 垯ãä¿æããããã«ãå¿æ¥åŠçœ®ããã³è¬ã§äœ¿çšãããå§åã«ææãªç²çããŒãã§ãã éæ°æ§ããŒãã¯ãéåžžãç®èã«ãã£ãããšä¿æããããã«ç¹å¥ã«èšèšãããäœåºæ¿æ§æ¥çå€ãæã£ãŠãããç®èãå·ã€ããããšãªãç°¡åã«åé€ããããšãã§ããŸãã 圌ãã¯ç°¡åã«ç©ºæ°ãç®èã«å°éããããšãå¯èœã«ããã®ã§ã圌ãã¯éæ°æ§ãåœããŠããŸãã 乳液ã®èªç±ãªå»åŠã®ççŽã®æ¥çå€ã¯ææã§ãå£ããããç®ã«èŠããã§ããæ£è ãšã®äž»èŠãªå©ç¹ãæäŸããŸãã ããã·ãªããžãŒããŒããªã©ã®éæ°æ§ããŒãã¯ãã³ããã³è£œã®æ¥çå€ã§äŒžçž®æ§ã®ããå 垯ã§ãã å€ç§ããŒãã¯ææãé²ãã®ãå©ããé žåäºéã... ãã£ãšèŠã
å¿èè¡ç®¡ã»ã³ãã³åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎ã°ããŒãã«å¿èè¡ç®¡ã»ã³ãã³åžå ŽèŠæš¡ãæšå®ããã 2026幎ã«1åç±³ãã«ã«çžåœããUSD 22.8ã«éããèŠèŸŒã¿ 2033幎10æãååç©ã®å¹Žéæé·ç(CAGR)ã7.2%å¢ 2026幎ïœ2033幎ãããã£ãŒã«å¿è¡ç®¡ã®ã¹ãã³ãã®åžå Žã¯çå®ã«æé·ããŠããŸããé転ãã㊠å åèçŸæ£ãèå人å£ã®å¢å ãããã³ æå°éã®äŸµè¥²çãªæé ã®æ¡çšã®å¢å ã ãã¯ãããžãŒ å»è¬åã®æ±ããçåè§£æ§ã®è¶³å Žãããã³ æ¹åãããã€ã¡ãŒãžæå°ã®æå°ã¯å¿è匷ãçµæãé«ããåŸæŒãããŸã èŠæ±ã ã¢ãããã»ã©ãã©ããªãŒãºããã¹ãã³ã»ãµã€ãšã³ã¹ã Medtronicã¯é©æ°ãã... ãã£ãšèŠã
ã«ãŒãã³ãããã¥ãŒã(CNT)åžå ŽèŠæš¡ãšäºæž¬ - 2026 - 2033幎ã°ããŒãã«ã«ãŒãã³ãããã¥ãŒãåžå ŽèŠæš¡ã¯ã 2026幎ã«1åç±³ãã«ã§ãUSD 4.7åç±³ãã«ã«éããèŠèŸŒã¿ 2033幎ã2026幎ãã13.4%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º 2033幎é ãããã£ãŒã«ã«ãŒãã³ãããã¥ãŒã(CNT)ã¯é«åºŠãª ããææåè¶ããæ©æ¢°ç匷床ã黿°äŒå°æ§ã ç±å®å®æ§ã è£œåæ¯èŠ³ã«ã¯ãã·ã³ã°ã«ãŠã©ãŒã«ã«ãŒãã³ãå«ãŸããŠããŸã ãããã¥ãŒã(SWCNT)ãšãã«ããŠã©ãŒã«ã«ãŒãã³ãããã¥ãŒã(MWCNT)ããããã ç°ãªãã¢ããªã±ãŒã·ã§ã³ãæäŸããã SWCNTsã¯é»åå·¥åŠã§åºãå©çšãããŠããŸãã... ãã£ãšèŠã
ãšããµã€ããŒã¬ãŒã¶ãŒããã€ã¹åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžççãªãšããµã€ããŒã¬ãŒã¶ãŒããã€ã¹åžå ŽèŠæš¡ãæšå®ããã 2026幎ã®USD 1.26ã§è©äŸ¡ãããUSD 2.34ã«éãããšäºæ³ããã 2033幎(æå20幎)10幎(æå20幎)ã«å¢æ®ç(CAGR)ã91%ã«å¢èš 2026幎ïœ2033幎ãããã£ãŒã«excimer ã¬ãŒã¶ãŒè£ 眮åžå Žã¯å°éã«ããã玫å€ç·ãå«ãã§ããŸã å»åŠã®é«ç²ŸåºŠã®é©çšã«äœ¿çšããã¬ãŒã¶ãŒ ã·ã¹ãã ã ç£æ¥ããã³ç§åŠåéã äž»èŠãªãããã¯ã ã¿ã€ãã¯å«ãã§ããŸã argon-fluoride(ArF)ãkrypton-fluoride(KrF)ãxenon-c... ãã£ãšèŠã
麻é ã®ã¬ã¹èžååš åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎ã°ããŒãã«éº»é ã¬ã¹èžååš åžå ŽèŠæš¡ã¯æšå®ããã 2026幎ã®USD 1.2åã§è©äŸ¡ãããUSD 2.3ã«éããèŠèŸŒã¿ 2033幎10æãååç©å¹Žéæé·ç(CAGR)ã92%å¢ 2026幎ïœ2033幎ãããã£ãŒã«éº»é ã®ã¬ã¹èžååšã¯ãäžè¬ã«èžçºåšãšããŠç¥ãããŠããããŸã ã§äœ¿çšãããå¿ é è£ çœ® ã¢ãã¹ãã·ã¢æ¶²äœã®éº»é ã®ä»£çåºãå¶åŸ¡ã«å€æããé éã·ã¹ãã æ£è ã®åžå ¥ã®ããã®èžæ°ã ãããã®ãããã¯ãã¯ä¿éããããã«èšèšãããŠããŸã 代çåºã®æ£ç¢ºãªéäžããã³å®å šãªç®¡çã®ãã㪠isofluraneãsevofluraneãããã³desflur... ãã£ãšèŠã
ããã£ã³ã³ã¿ãŒããã€ã¹åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎ã°ããŒãã«ããã£ã³ã³ã¿ãŒããã€ã¹åžå ŽèŠæš¡ã¯ã 2026幎ã®USD 4.2åã§è©äŸ¡ãããUSD 7.8ã«éãããšäºæž¬ããã 2033幎10æãååç©å¹Žéæé·ç(CAGR)ã93%å¢å 2026幎ãã2033幎ãŸã§ã®äºæž¬æéããããã£ãŒã«ããã£èŒªéãæãè£ çœ®åžå Žã¯é䟵襲çãªç¯å²ãå«ãã§ããŸã èèªãæžããããã«èšèšãããæå°éã«äŸµç¥çãªæè¡ã¯ããã€ãç· ããŸã ç®ã¯ãããã£åœ¢ãæ¹åãã å ±éã®ãããã¯ãã¯cryolipolysisãå«ãã§ããŸã èèªçްèãåçµããã·ã¹ãã , ããŒã ãã£ãã·ã¥ã®é«åšæ³¢è£ çœ® ç®ã®ãã€ãç· ãŸãããšã®ããã«... ãã£ãšèŠã
é䟵襲ç㪠Hemodynamic ã®ã¢ãã¿ãªã³ã° ã·ã¹ãã åžå Žã®ãµã€ãºããã³ äºæž¬ â 2026 â 2033äžçã®é䟵襲ç㪠Hemodynamic ã®ã¢ãã¿ãªã³ã° ã·ã¹ãã åžå Žã®ãµã€ãºã¯ãããŸã 2026幎ã®USD 1.85åã§è©äŸ¡ããããšäºæ³ããã 2033幎ãŸã§ã«USD 3.7åã«éããååç©ã®å¹Žéæé·çã瀺ã 2026幎ãã2033幎ãŸã§ã®10.5%ã®CAGRããããã£ãŒã«é䟵襲çãªå€åŸ©èª¿è£ 眮ã¢ãã¿ãªã³ã° ã·ã¹ãã ã¯é«åºŠã®å»åŠã§ã å¿ èŠæ§ãªãã§å¿è¡ç®¡ã®æ§èœãè©äŸ¡ããããã«äœ¿çšãããè£ çœ® 䟵ç¥çãªã«ããŒãã«ã ãããã®ã·ã¹ãã ã¯ãå¿èãªã©ã®ãã©ã¡ãŒã¿ã枬å®ããŸã åºåãè¡å§ãææã®å®¹... ãã£ãšèŠã
ããã²ã³å€ç§å€©äºã¯åžå Žã®ãµã€ãºããã³äºæž¬ãã€ããŸãâ 2026幎ïœ2033幎äžçã®ããã²ã³å€ç§å€©äºç¯ã®åžå Žã®ãµã€ãºã¯æšå®ãããŸã 2026幎ã®USD 430,000,000ã§è©äŸ¡ãããUSD 715ã«éãããšäºæ³ããã 2033幎ãŸã§ã«ãååç©ã®å¹Žéæé·ç(CAGR)ã7.2%å¢ 2026幎ïœ2033幎ãããã£ãŒã«ããã²ã³å€ç§å€©äºç¯ã¯èšèšãããŠããå»åŠã®ç §æã·ã¹ãã ã§ã å€ç§ã®éã«é«èŒåºŠã圱ãªãã®ç §æãæäŸãããã æé ã ãããã®ã©ã€ãã¯æãããçœãäœãåºãããã²ã³çæ ¹ã䜿çšããŸã åªç§ãªè²ã®ã¬ã³ããªã³ã°ãšã®ã©ã€ãã¯ãå€ç§å»ãæããã«ããããšãå¯èœã«ããŸã çµç¹ãšè¡ç®¡ãèŠèŠåããŸãã äž»èŠãª... ãã£ãšèŠã
Xç·æ€åºå¯èœãªã¬ãŒãŒã¹ãã³ãžåžå ŽèŠæš¡ãšäºæž¬ - 2026 - 2033ã°ããŒãã«Xç·æ€åºå¯èœ ã¬ãŒãŒã¹ãã³ãž åžå ŽèŠæš¡ã¯2026幎ã«320çŸäžç±³ãã«ã§è©äŸ¡ããã2033幎ãŸã§ã®9.8%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããUSD 620çŸäžç±³ãã«ã«éãããšäºæ³ãããããããã£ãŒã«å šäœçãªXç·ã®æ€åºå¯èœãªã¬ãŒãŒã®ã¹ãã³ãžã¯äœåéšå±ã§äœ¿çšãããå°éã«ãããå€ç§æ¶èåã§ãããåºè¡ãå¶åŸ¡ããç·æ¥ã®å¿é ã¯ãæ¶²äœãåžåããå€ç§ææãæ£è äžæ®ã£ãŠããããšãä¿éããŸããã ãããã¯ãããªãŠã ç¡«é žå¡©ãéå±ã¹ããªãããªã©ã®æŸå°æ§å çŽ ã§åã蟌ãŸããŠãããXç·ã€ã¡ãŒãžã³ã°ã®äžã§ãããã衚瀺ããŸãã ãããã®ã¹ãã³ãž... ãã£ãšèŠã
ç±³åœããã³ãšãŒãããã®èªå泚å°åšåžå Žãã¿ã€ãå¥ïŒäœ¿ãæšãŠããã³åå©çšå¯èœïŒãååã¿ã€ãå¥ïŒçç©åŠç補å€ããã«ã¢ã³ãäœååãªã©ïŒãé©å¿çå¥ïŒã¢ããã£ã©ãã·ãŒãç³å°¿ç ãèªå·±å ç«çŸæ£ãå€çºæ§ç¡¬åçãçé çããã«ã¢ã³é害ãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ãåšå® å»çæœèšã倿¥æè¡ã»ã³ã¿ãŒãªã©ïŒ... ãã£ãšèŠã